| S. No. | Title | Funding Agency | Amount (lakh) | Duration |
| COMPLETED |
| 1. | Nano-carriers for co-delivery of small molecules and oligonucleotides | BITS, Pilani | 2.00 | 2014-1026 |
| 2. | Development of Nano-Carriers for Improved Drug Delivery. | BITS, Pilani | 9.90 | 2015-2017 |
| 3. | Combination delivery of small molecules and microRNA for treatment of locally advanced and metastatic breast cancer. | DST-SERB | 27.20 | 2015-2018 |
| 4 | Exploring the synergism of PPARγ agonist and HDAC inhibitor or on reversal of Alzheimer's type of dementia and developing their brain targeted nano-carrier system for effective treatment. | DST-Nanomission | 31.13 | 2017-2020 |
| 5. | Nanotechnology based pharmaceuticals, nutraceuticals and cosmetics: development of platform technology. | Incisive Element LLC, USA | 21.37 | 2017-2020 |
| 6. | Peptide-decorated pH-sensitive nano-conjugate hybrid micelles for co-delivery of temozolamide and an autophagy inducer, rapamycin, for treatment of glioblastoma multiforme. | DBT-Nanobiotechnology | 41.962 | 2018-2021 |
| 7. | cRGD decorated lipo-polymeric nanoplexes of CRISPR/Cas9 ribonucleoprotein (RNP) for the management of retinal dystrophic conditions | DBT-Nano-intervention in Management of Opthalmic Diseases | 125.214 | 2018-2022 |
| 8. | Actively targeted nano-formulations for co-delivery of a taxane and antioxidant molecule, alpha lipoic acid, for treating breast cancer. | DST-Rajasthan | 11.136 | 2018-2021 |
| ONGOING PROJECTS (As Principle Investigator) |
| 1 | Setting up a DST supported Technology Enabling Center (TEC) at BITS Pilani | DST-TDT Division (As co-ordinator) | Recommended |
| 2. | Methylated cfDNA as a pathological biomarker for the development of a CRISPR/Cas based molecular diagnostic tool | DST Interdisciplinary Cyber-Physical Systems (NM-ICPS) | 38.5712 | 15th Sept 2022- 14th March 2023 |
| 3. | DBT-BUILDER -University of Birla Institute of Technology and Science Pilani, Pilani Campus Interdisciplinary Life Science Programme for Advanced Research and Education in Epigenetics and Genome editing | DBT-BUILDER (As PI team member) | 901.80320 | 25th Sept 2021- 24th Sept 2026 |
| 4 | Self-assembling, pH-sensitive temozolomide conjugate nanomedicine for treatment of glioblastoma multiforme, | ICMR | 25.22 | 24th Sept 2019- 24th Sept’ 2022 |
| As co-investigator |
| 1. | Gel-based composite formulation containing asiaticoside and neurotensin for rapid healing of diabetic wounds. | ICMR | 29.83 | 2019-2022 |
| 2. | Peptide-tethered multifunctional cationic nanocomplexes for delivery of IL-1 receptor antagonist for | DST-SERB | 40.4695 | 2020-2023 |